A Clinical Trial to Evaluate the Food Effect of CKD-378

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 3, 2024

Primary Completion Date

June 3, 2024

Study Completion Date

June 13, 2024

Conditions
Type II Diabetes Mellitus
Interventions
DRUG

CKD-378, QD, PO

CKD-378, QD, PO

Trial Locations (1)

10099

Gimpo Woori hospital, Gimpo-si

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT06386328 - A Clinical Trial to Evaluate the Food Effect of CKD-378 | Biotech Hunter | Biotech Hunter